FIELD: biotechnology.
SUBSTANCE: NDVH-2 strain of the Newcastle disease virus is deposited in the State Collection of Viruses of the Virusology Research Institute named after D. I. Ivanovsky of the Ministry of Health of Russia under the registration number 2780. The strain is capable of selectively lysing human tumour cell lines without causing an infectious disease and mammalian death.
EFFECT: study of a possibility of development of a viral oncolytic drug for the therapy of human malignant tumours, with a view to further application in medical virology, biotechnology, microbiology and oncology.
1 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEWCASTLE DISEASE VIRUS STRAIN FOR STUDYING ONCOLYTIC PROPERTIES AND MECHANISMS OF ONCOLYSIS TO CREATE PROTOTYPE ANTICANCER PREPARATION | 2014 |
|
RU2562115C1 |
| NEWCASTLE DISEASE VIRUS STRAIN FOR CREATING BASED ANTICANCER CANDIDATE PREPARATION AND STUDYING OF ONCOLYSIS MECHANISMS | 2010 |
|
RU2482129C2 |
| STRAIN OF ENTEROVIRUS COXSACKIE B6 SELECTIVELY INFECTING AND LYSING TUMOROUS HUMAN CELLS in vitro | 2012 |
|
RU2496873C1 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2008 |
|
RU2379055C1 |
| NEWCASTLE DISEASE VIRUS STRAIN USED IN SERUM DIAGNOSIS OF NEWCASTLE DISEASE IN HEMAGGLUTINATION INHIBITION TEST | 2010 |
|
RU2482184C2 |
| RECOMBINANT PLASMID DNA pcDNA4-Apo-2NLS2 CARRYING SYNTHETIC GENE OF APOPTIN PROTEIN INDUCING p53-INDEPENDENT PROGRAMMED TUMOUR CELL DEATH | 2013 |
|
RU2541777C1 |
| NEWCASTLE DISEASE VIRUS "VNIIZZH G7" STRAIN FOR PRODUCTION OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF NEWCASTLE DISEASE OF BIRDS | 2024 |
|
RU2821028C1 |
| SET OF OLIGONUCLEOTIDE PRIMERS FOR PRIMARY STRUCTURE F NEWCASTLE DISEASE VIRUS GENE CLASS I | 2015 |
|
RU2590718C1 |
| METHOD FOR IMMUNE THERAPY OF ONCOLOGICAL DISEASES AND PHARMACEUTICAL COMPOSITIONS OF ONCOLYTIC SENDAI VIRUS | 2012 |
|
RU2519763C9 |
| RECOMBINANT STRAIN VV-GMCSF-Lact OF VACCINIA VIRUS, HAVING ONCOLYTIC ACTIVITY AND PRODUCING GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR AND ONCOTOXIC LACTAPTIN PROTEIN | 2015 |
|
RU2604187C1 |
